Registry of Acute Ischemic Stroke With Large- or Medium-vessel Occlusion (LOMEVO)

Capital Medical University

Status: Enrolling

Conditions: Acute Ischemic Stroke

Treatments: Other: Visit at D90

Study type: Observational

Funder types: Other

Identifiers

NCT05779215

XMEC-2023-002

Details and patient eligibility

About

This study is designed to observe the treatment options in real-world clinical practice as well as the safety and efficacy of different treatment strategies.

Full description

LOMEVO is a prospective, multicenter, real-world registry lasting for 10 years. A total of 50000 patients with large- or medium-vessel occlusion will be enrolled at approximately 30 centers around China.

Enrollment: 50,000 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• The clinical diagnosis is acute ischemic stroke with large- or medium- vessel occlusion (the criteria followed the Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018)
• Informed consent from the patient or surrogate

Exclusion criteria

• No additional exclusion criteria

Trial design

50,000 participants in 1 patient group

acute ischemic stroke with large- or medium-vessel occlusion

Description:

acute ischemic stroke patients with large- or medium-vessel occlusion including all treatments.

Treatment:

Other: Visit at D90